|
Fusion gene ID: 10683 |
FusionGeneSummary for DUS2_HSD11B2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: DUS2_HSD11B2 | Fusion gene ID: 10683 | Hgene | Tgene | Gene symbol | DUS2 | HSD11B2 | Gene ID | 54920 | 3291 |
Gene name | dihydrouridine synthase 2 | hydroxysteroid 11-beta dehydrogenase 2 | |
Synonyms | DUS2L|SMM1|URLC8 | AME|AME1|HSD11K|HSD2|SDR9C3 | |
Cytomap | 16q22.1 | 16q22.1 | |
Type of gene | protein-coding | protein-coding | |
Description | tRNA-dihydrouridine(20) synthase [NAD(P)+]-likeSMM1 homologdihydrouridine synthase 2-like, SMM1 homologtRNA-dihydrouridine(20) synthase (NAD(P)(+))up-regulated in lung cancer protein 8 | corticosteroid 11-beta-dehydrogenase isozyme 2-HSD11 type II11-DH211-HSD type II11-beta-HSD type II11-beta-HSD211-beta-hydroxysteroid dehydrogenase type 211-beta-hydroxysteroid dehydrogenase type IINAD-dependent 11-beta-hydroxysteroid dehydrogenas | |
Modification date | 20180522 | 20180519 | |
UniProtAcc | Q9NX74 | P80365 | |
Ensembl transtripts involved in fusion gene | ENST00000565263, ENST00000358896, ENST00000432752, | ENST00000567684, ENST00000326152, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 4 X 5 X 3=60 |
# samples | 2 | 5 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(5/60*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: DUS2 [Title/Abstract] AND HSD11B2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | DUS2 | GO:0060548 | negative regulation of cell death | 18096616 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | SKCM | TCGA-EB-A3Y7-01A | DUS2 | chr16 | 68105011 | + | HSD11B2 | chr16 | 67470152 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000565263 | ENST00000567684 | DUS2 | chr16 | 68105011 | + | HSD11B2 | chr16 | 67470152 | + |
5CDS-3UTR | ENST00000565263 | ENST00000326152 | DUS2 | chr16 | 68105011 | + | HSD11B2 | chr16 | 67470152 | + |
5CDS-3UTR | ENST00000358896 | ENST00000567684 | DUS2 | chr16 | 68105011 | + | HSD11B2 | chr16 | 67470152 | + |
5CDS-3UTR | ENST00000358896 | ENST00000326152 | DUS2 | chr16 | 68105011 | + | HSD11B2 | chr16 | 67470152 | + |
5CDS-3UTR | ENST00000432752 | ENST00000567684 | DUS2 | chr16 | 68105011 | + | HSD11B2 | chr16 | 67470152 | + |
5CDS-3UTR | ENST00000432752 | ENST00000326152 | DUS2 | chr16 | 68105011 | + | HSD11B2 | chr16 | 67470152 | + |
Top |
FusionProtFeatures for DUS2_HSD11B2 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
DUS2 | HSD11B2 |
Dihydrouridine synthase. Catalyzes the synthesis ofdihydrouridine, a modified base found in the D-loop of most tRNAs.Negatively regulates the activation of EIF2AK2/PKR.{ECO:0000269|PubMed:15994936, ECO:0000269|PubMed:18096616}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for DUS2_HSD11B2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for DUS2_HSD11B2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
DUS2 | TK1, SMN1, PVRL2, KANSL1 | HSD11B2 | KAT2B, KAT2A, CTBP1, HDAC1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for DUS2_HSD11B2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | HSD11B2 | P80365 | DB01185 | Fluoxymesterone | Corticosteroid 11-beta-dehydrogenase isozyme 2 | small molecule | approved|illicit |
Tgene | HSD11B2 | P80365 | DB00741 | Hydrocortisone | Corticosteroid 11-beta-dehydrogenase isozyme 2 | small molecule | approved|vet_approved |
Top |
RelatedDiseases for DUS2_HSD11B2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | HSD11B2 | C3887949 | Apparent mineralocorticoid excess | 12 | CTD_human;UNIPROT |
Tgene | HSD11B2 | C0020538 | Hypertensive disease | 4 | CTD_human;HPO |
Tgene | HSD11B2 | C0004096 | Asthma | 1 | CTD_human |
Tgene | HSD11B2 | C0011854 | Diabetes Mellitus, Insulin-Dependent | 1 | CTD_human |
Tgene | HSD11B2 | C0023890 | Liver Cirrhosis | 1 | CTD_human |
Tgene | HSD11B2 | C0027051 | Myocardial Infarction | 1 | CTD_human |
Tgene | HSD11B2 | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
Tgene | HSD11B2 | C0032962 | Pregnancy Complications | 1 | CTD_human |
Tgene | HSD11B2 | C0342488 | Mineralocorticoid Excess Syndrome, Apparent | 1 | CTD_human;ORPHANET |